Summary & Overview
HCPCS Q0513: Pharmacy Dispensing Fee for Inhalation Drug(s), 30 Days
HCPCS Level II code Q0513 denotes a pharmacy dispensing fee for inhalation drug(s), billed on a per-30-day basis. This fee code is used nationally to capture dispensing costs separate from drug acquisition and administration, supporting claims processing and reimbursement for pharmacies that supply inhaled therapies on a monthly cycle. The code is particularly relevant for chronic respiratory therapies such as maintenance inhalers and nebulized medications that are dispensed regularly.
Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise breakdown of how Q0513 is positioned in claims workflows, what service settings typically use the code, and the clinical context for inhalation therapies that drive its utilization. The publication provides benchmarks and coverage considerations, highlights common modifiers and billing practices associated with dispensing fees, and outlines how payers commonly handle separate dispensing fees versus drug reimbursement.
The content is aimed at billing professionals, pharmacy managers, and policy analysts seeking a national overview of the code’s role in reimbursement and claims adjudication, plus practical context for where and when the code is applied.
Billing Code Overview
HCPCS Level II code Q0513 represents a pharmacy dispensing fee for inhalation drug(s) billed per 30 days. This code captures the charge associated with dispensing inhaled medications that are intended for use over a 30-day supply.
-
Service type: Pharmacy dispensing for prescription inhalation medications
-
Typical site of service: Pharmacy (retail or outpatient pharmacy filling a 30-day supply)
Clinical & Coding Specifications
Clinical Context
A typical patient is an adult or pediatric individual with a chronic or acute respiratory condition requiring a prescribed inhalation medication delivered via metered-dose inhaler, nebulizer solution, or dry powder inhaler. The patient presents to an outpatient pharmacy after receiving a prescription from a primary care physician, pulmonologist, or emergency department clinician. The pharmacy processes the prescription, dispenses a 30-day supply of the inhalation drug, and applies the pharmacy dispensing fee represented by Q0513. Clinical workflow steps include prescription receipt, verification of the medication and dose, insurance eligibility and benefit checks, patient counseling on inhaler technique and device maintenance, labeling, and documentation of dispensing in the pharmacy record. This service commonly follows a clinical encounter coded for conditions such as asthma, chronic obstructive pulmonary disease (COPD), bronchiectasis, cystic fibrosis exacerbation, or acute bronchitis where inhaled therapy is indicated. The typical site of service is an outpatient retail or specialty pharmacy; dispensing may also occur in hospital outpatient pharmacies or clinic-based pharmacies that provide outpatient fills for a 30-day supply.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
22 | Increased procedural services | Use when pharmacy documents and bills for unusually high complexity of dispensing or extensive counseling beyond typical pharmacy dispensing for a 30-day inhalation drug supply. |